Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer 09.02.2024 1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
Ep153: Rick Young on Studying Gene Expression for Drug Discovery 22.01.2024 1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.
Ep152: Jens Eckstein on Investing in Healthy Aging 10.01.2024 1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer 26.12.2023 1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance 13.12.2023 1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.
Ep149: Nancy Stagliano on Precision Neuroscience 29.11.2023 1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.
Ep148: Diana Brainard on the Fight Against Infectious Disease 13.11.2023 1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.
Ep147: Reid Huber on Investing in the Future of Medicine 01.11.2023 1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.
Ep146: Jeff Huber on Life in Tech and Biotech 17.10.2023 1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer 03.10.2023 1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.
Ep144: Turning the Tables, Rob Perez Interviews Me 19.09.2023 1:04:58
Turning the Tables, Rob Perez Interviews Me
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders 06.09.2023 1:10:25
Zach Weinberg and Alexis Borisy of Curie. Bio on Freeing the Biotech Founders
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be 24.08.2023 55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets 08.08.2023 1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas 24.07.2023 1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.
Ep139: Kevin Conroy on Early Detection of Cancer 10.07.2023 1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.
Ep138: Jodie Morrison on Becoming a Biotech CEO 27.06.2023 1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.
Ep137: Aaron Ring on Immunotherapy for Cancer & More 14.06.2023 56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.
Ep136: Deborah Palestrant on Building Biotech Startups 30.05.2023 52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.
Ep135: John Maraganore on Developing a New Class of Medicines 08.05.2023 1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies 24.04.2023 1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies 12.04.2023 1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.
Ep132: Eric Dobmeier on Treating Kidney Disease 28.03.2023 1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.
Ep131: Ryan Watts on Neuroscience Drug R&D 14.03.2023 1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave 28.02.2023 1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.
Similar podcasts
Listen to the The Long Run with Luke Timmerman podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
